Phlpp1 Expression in Osteoblasts Plays a Modest Role in Bone Homeostasis

Area of Science:

• Bone Biology
• Cellular and Molecular Biology
• Endocrinology

Background:

• Previous studies indicated Phlpp1 deficiency impacts bone mass and limb length.
• The specific cell types and mechanisms underlying Phlpp1's role in bone were not fully understood.

Purpose of the Study:

• To investigate the function of Phlpp1 in bone-forming osteoblasts.
• To determine the necessity of Phlpp1 for its effects on bone.

Main Methods:

• Generated conditional knockout mice (Phlpp1 cKO_Col1a1) by crossing Phlpp1 floxed mice with type 1 collagen-Cre mice.
• Assessed bone mineralization, gene expression, microarchitecture, and histomorphometry in knockout mice.
• Utilized micro-computed tomography and bone histomorphometry for quantitative analysis.

Main Results:

• Phlpp1 ablation in osteoblasts did not alter bone mineralization or peak bone mass attainment.
• Elevated levels of inflammatory genes (Ifng, Il6, Ccl8) and increased RANKL/OPG ratios were observed.
• Compromised femoral bone microarchitecture was noted in female Phlpp1 cKO_Col1a1 mice.

Conclusions:

• Phlpp1 deletion in type 1 collagen-expressing cells does not significantly affect peak bone mass.
• Phlpp1 deficiency may promote inflammatory gene expression and alter the RANKL/OPG balance.
• Further investigation into Phlpp1's role in aging, inflammation, osteocytes, and its redundancy with Phlpp2 is warranted.